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Objectives. This study attempted to determine the relation 
between infarct size after acute myocardial infarction and subse- 
quent left ventricular remodeling using precise clinical measure- 
ments. 
Background. Animal studies have demonstrated that the degree 
of left ventricular emodeling after myocardial infarction is 
linearly related to infarct size. Clinical studies have not clearly 
replicated these results because of imprecise measurements and 
failure to adjust for patency of the infarct-related artery. 
Methods. Infarct size was measured from technetium-99m 
(Tc-99m) sestamibi perfusion images in 14 patients (12 with an 
anterior, 2 with an inferior infarction) by a threshold method 
previously described and expressed as percent of the left ventricle 
(32 -+ 17% left ventricle [mean -+ SD], range 6% to 58%). Absolute 
end-systolic volume, end-diastolic volume and ejection fraction 
were determined by electron beam computed tomographic images 
performed at discharge and at 6 weeks, 6 months and 1 year after 
myocardial infarction. All patients had documented infarct- 
related artery patency after reperfusion therapy. 
Results. At hospital discharge, there was no correlation between 
infarct size and end-systolic and end-diastolic volumes or ejection 
fraction. There was significant left ventricular dilation in the 
study group over the next year. As remodeling progressed, there 
was closer correlation between infarct size and ejection fraction 
and end-systolic volume measures (infarct size vs. end-systolic 
volume, from r = 0.43 at discharge to r = 0.80 at 1 year; infarct 
size vs. ejection fraction, from r = -0.39 at discharge to r = -0.84 
at 1 year). There was a strong inverse correlation between infarct 
size at discharge and subsequent changes over the next year in 
end-systolic volume (r = 0.63, p = 0.02) and ejection fraction (r = 
-0.66, p = 0.01). 
Conclusions. Infarct size as measured by Tc-99m sestamibi at 
hospital discharge after an index infarction is predictive of 
subsequent change in left ventricular volume and function in the 
year after myocardial infarction. Patients with a large infarct 
demonstrated the greatest degree of dilation in the setting of 
patency of the infarct-related artery. 
(J Am CoU Cardiol 1995;25:567-73) 
Left ventricular volumes and ejection fraction have been 
shown to be major predictors of survival after acute myocardial 
infarction (1,2). However, these variables may change over 
time because of left ventricular remodeling. Dilation of the left 
ventricle has been shown to occur rapidly and progressively in 
the weeks after myocardial infarction. In animal studies (3,4), 
the degree of subsequent dilation is linearly related to the 
extent of myocardial necrosis. Previous clinical studies exam- 
ining this issue have been limited by imprecise measures of 
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infarct size and left ventricular volumes and function, as well as 
failure to adjust for patency of the infarct-related artery. 
Technetium-99m (Tc-99m) sestamibi tomographic maging 
is an accurate and reproducible method for determining infarct 
size that is unaffected by myocardial stunning (5). Previous 
studies have demonstrated excellent correlation with other 
indirect measures of infarct size (5-7) and highly significant 
correlation with pathologic infarct size from explanted human 
hearts (8). Electron beam computed tomography provides 
accurate, noninvasive measurements of left ventricular systolic 
and diastolic chamber volumes and function. Reproducibility 
and accuracy of electron beam computed tomographic mea- 
surements have been validated extensively in both animal and 
human studies (9-15). This study compared serial changes in 
electron beam computed tomographic measurements of left 
ventricular size and function in the year after acute myocardial 
infarction with infarct size measured at hospital discharge by 
Tc-99m sestamibi in patients with a patent infarct-related 
artery. 
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Methods  
Patients. The study group included a series of patients 
enrolled in a prospective trial of Tc-99m scstamibi from May 
1988 to August 1989 who met the following criteria: 1) chest 
pain ->30 min in duration; 2) electrocardiographic (ECG) ST 
segment elevation ->0.1 mV in two or more leads in the same 
vascular territory; 3) successful reperfusion therapy within 12 h 
of the onset of chest pain documented by coronary angiogra- 
phy; 4) elevated creatine kinase-MB isoenzymes within 24 h of 
chest pain; 5) pathologic Q waves on a discharge 12-lead ECG; 
and 6) electron beam computed tomographic s anning at at 
least three prospectively defined points in time. Patients were 
excluded if they had a previous myocardial infarction. No 
patient had a recurrent myocardial infarction or congestive 
heart failure between hospital discharge and 1 year later. 
Reperfusion therapy. Intravenous thrombolysis was per- 
formed with recombinant tissue-type plasminogen activator 
(six patients) using previously described methods (16). Direct 
coronary angioplasty was performed in eight patients. 
Coronary angiography. Patients undergoing direct coro- 
nary angioplasty had angiography immediately (mean time to 
angiography 5.5 _+ 4.0 h), whereas patients who underwent 
thrombolysis generally had angiography later in their hospital 
course (mean time to angiography 24 _+ 27 h, range 3.6 to 72). 
The infarct-related artery was identified by a combination of 
the ECG, left ventriculogram and coronary angiogram. 
Radionuclide imaging. All patients received an injection of 
20 to 30 mCi of Tc-99m sestamibi at discharge (7 _ 2 days from 
admission, range 4 to 9). Tomographic imaging was performed 
1 to 6 h later with 30 images over a 180 o arc, 45 ° right anterior 
oblique to 45 ° left posterior oblique using a step and shoot 
mode (17). Perfusion defect size was quantitated from the sum 
of five short-axis lices and determined from the number of 
pixels with <60% of maximal counts over the five slices (17). 
Infarct size was determined by the extent of the perfusion 
defect and expressed as percent of the left ventricle (17,18). 
This method of quantifying infarct size has correlated closely 
with other methods of assessing infarct size (5-7), and the 60% 
threshold has been shown to provide the optimal separation 
between viable and nonviable myocardium (19). 
Computed tomography. Electron beam computed tomo- 
graphic imaging (Imatron C-100) of each subject was per- 
formed as previously described (15,20). Polytomographic im- 
ages of the heart were obtained at a rate of 17 frames/s from 
prospective ECG triggering at the R wave (end-diastole). Each 
tomographic level was 0.8 em thick, with a fixed center-to- 
center distance between levels of 1 cm. Details of the electron 
beam scanner design and operation have been described 
elsewhere (21). 
Computed tomographic mages were acquired and pro- 
cessed using previously described techniques (9,10). No pre- 
medications were administered, and cardiac medications were 
withheld at least 4 h before scanning to avoid possible acute 
hemodynamic effects. Each subject was positioned in the 
scanner to obtain parallel tomographic images in the short axis 
(transverse cardiac) from the left ventricular apex to the base 
of the right ventricular outflow tract (12). A noncontrast agent 
localization scan was performed to localize the left ventricular 
apex, and the patient was mechanically adjusted within the 
scanner to ensure that the most caudad tomographic slice was 
obtained one slice below the apex (12). A bolus intravenous 
injection of 10 ml of a dilute solution of magnesium sulfate 
(0.2%) was administered, allowing an estimation ofcirculation 
time during normal respiration (20). During imaging, an 
intravenous infusion of nonionie contrast medium was deliv- 
ered at 3 ml/s for 20 s. Image acquisition was initiated at the 
"circulation time," which ensured excellent and simultaneous 
opacification of the left and right ventricular chambers at all 
levels scanned. Thirteen consecutive frames through the car- 
diac cycle beginning at the ECG R wave were obtained at six 
contiguous, parallel tomographic levels. After a 2- to 5-min 
interval, the scanning table was advanced 6 cm, and triggered 
imaging was repeated with contrast medium. Most patients 
could be imaged adequately using two scanning runs; however, 
some patients, because of marked ventricular dilation, re- 
quired a third run for a total of 18 slices. 
Electron beam scanning was performed at four points in 
time: at hospital discharge (8 _ 1 days) and at 6 weeks (61 _+ 
3 days), 6 months (213 _+ 8 days) and 1 year (398 _ 7 days) 
after acute myocardial infarction. 
Determination of left ventricular volumes and ejection 
fraction. Data were analyzed in an identical manner for all 
patients at each of the four electron beam computed tomo- 
graphic studies. The end-diastolic (related temporally to the R 
wave on the ECG) and end-systolic (smallest chamber volume 
during the cardiac ycle) frames were first identified at each 
tomographic level (9-13,15). The area inscribing the endocar- 
dial surface at each level of the left ventricle was determined 
using previously published criteria (9). Images were analyzed 
from the apical through the basal tomographic sections, which 
generally constituted analysis from 12 separate tomographic 
slices/study. Tomographic left ventricular volumes were the 
product of end-diastolic or end-systolic tomographic area and 
slice thickness. Using a modified Simpson's rule, global (or 
total) chamber volumes were obtained by summing the tomo- 
graphic chamber (end-diastolic or end-systolic) volumes over 
all slices from the apex though the ventricular outflow tract. 
The ejection fraction was obtained by the following equation: 
(End-diastolic - End-systolic)/End-diastolic volumes. 
Statistical evaluation. Data are presented as mean value _+ 
SD. Simple linear regression was used to correlate Tc-99m 
scstamibi infarct size with computed tomographic determina- 
tions of ejection fraction, end-systolic and end-diastolic vol- 
umes and hemodynamic variables at discharge and at 6 weeks, 
6 months and 1 year and subsequent changes in these variables. 
Analysis of variance was used to analyze repeated measures of
ejection fraction and end-systolic and end-diastolic volumes. 
Multiple linear regression analysis was performed to test 
whether a change in hemodynamic variables (heart rate, 
systolic and diastolic blood pressure) provided an independent 
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Table 1. Clinical Characteristics of the Study Group 
Reperfusion Residual End-Systolic Volume (ml) Ejection Fraction 
IRA Infarct 
Pt No./ Age MI Time Stenosis Size 1-yr 1-yr 
Gender (yr) IRA Location Modality (rain) (%) (% LV) Dis. 6wk 6 mo lyr Change Dis. 6wk 6too 1 yr Change 
I/M 64 LAD Ant PTCA 540 10 31 50 56 72 79 29 0.62 0.59 0.53 0.56 -0.06 
2/M 50 RCA Inf rt-PA 175 50 31 58 64 69 76 18 0.54 0.52 0.53 0.52 -0.02 
3/M 56 LAD Ant rt-PA 287 40 16 52 41 45 39 -13 0.55 0.65 0.66 0.70 0.15 
4/M 71 LAD Ant PTCA 190 30 54 96 82 10t 121 25 0.39 0.44 0.42 0.33 -0.06 
5/M 64 LAD Ant rt-PA 215 30 58 42 80 76 81 39 0.69 0.48 0.53 0.50 -0.19 
6/M 43 RCA Inf PTCA 291 30 1l 45 53 55 58 I3 0.67 0.68 0.65 0.66 -0.01 
7/F 49 LAD Ant PTCA 338 30 13 31 35 35 38 7 0.77 0.75 0.77 0.75 -0.02 
8/M 47 LAD Ant PTCA 202 30 49 70 71 73 89 19 0.54 0.56 0.56 0.56 0.02 
9!M 40 LAD Ant PTCA 109 30 17 71 77 - -  75 4 0.57 0.54 --  0.56 -0.01 
10/'M 70 LAD Ant PTCA 403 20 50 65 77 95 85 20 0.56 0.50 0.52 0.46 -0.10 
ll/M 50 LAD Ant PTCA 91 30 36 45 83 78 104 59 0.68 0.55 0.51 0.49 -0.19 
12/M 72 LM) Ant rt-PA 245 20 21 65 54 75 72 7 0.58 0.65 0.56 0.58 0 
13/M 68 LAD Ant rt-PA 163 20 48 47 72 76 102 55 0.60 0.44 0.47 0.41 -0.19 
14/M 58 LAD Ant rt-PA 160 30 6 36 39 45 46 10 0.65 0.63 0.68 0.71 0.06 
Ant = anterior; Dis. = discharge; F = female; Inf - inferior; IRA = infarct-related artery; LAD = left anterior descending coronary artery; LV = left ventricle; 
M = male; M1 = myocardial infarction; Pt - patient; PTCA - percutaneous transluminal coronary angioplasty; RCA = right coronary artery; rt-PA --- recombinant 
tissue-type plasminogen activator. 
effect on changes in ventricular volumes and function after 
adjustment for infarct size. 
Resul ts  
Patient demographics (Table 1). The study group included 
14 patients (13 men, 1 woman; mean age [SD] 57 _+ 11, range 
40 to 72 years; 12 with an anterior, 2 with an inferior 
infarction). Eight patients had successful direct coronary an- 
gioplasty and six thrombolysis as the primary therapy for acute 
myocardial infarction; five of six patients had a patent infarct- 
related artery at subsequent angiography. All six patients 
treated with thrombolysis underwent successful coronary an- 
gioplasty within 3 days after the acute infarction. All patients 
demonstrated a patent infarct-related artery (Table 1) at the 
completion of coronary angioplasty (29 + 10% residual lumen 
stenosis, range 10% to 50%). 
Most patients were receiving some form of antianginal 
medication at discharge and at subsequent scan visits. At 
discharge and at 6 weeks, 6 months and 1 year, the number of 
patients who were receiving beta-receptor blocking agents 
were 11, 10, 9 and 6, respectively; long-acting nitrates 10, 9, 8 
and 8, respectively; and calcium antagonists 7, 3, 3 and 4, 
respectively. Only one patient received an angiotensin- 
converting enzyme inhibitor starting at 6 weeks. No patient 
experienced recurrent angina or infarction or underwent re- 
peat coronary angioplasty or coronary artery bypass graft 
surgery during the year after the index infarction, and all 
patients were ambulatory. 
Radionuclide measurements (Table 1). Mean infarct size 
estimated at discharge by Tc-99m sestamibi tomographic im- 
aging was 32 +_ 17% of the left ventricle (range 6% to 58%). 
Hemodynamic and computed tomographic measurements 
(Tables 1 and 2, Fig. 1). There was significant dilation of the 
left ventricle in the ensuing year from the index infarction. 
Both end-systolic (Fig. 1) and end-diastolic volumes demon- 
strated significant increases that were both unidirectional nd 
progressive. However, left ventricular ejection fraction for the 
group as a whole was preserved (Table 2). There were signif- 
icant changes in heart rate and blood pressure within patients 
at the time of the four computed tomographic s ans (Table 2). 
Changes in systolic blood pressure were not unidirectional, and 
there was no correlation with changes in left ventricular 
function or volumes. However, there was a progressive in- 
crease in diastolic blood pressure that was linearly related to 
the change in end-systolic volume (p -- 0.006) and inversely 
related to ejection fraction (p = 0.06). Despite a significant 
change in heart rate during the four scans, there was no 
significant relation between heart rate and changes in ejection 
fraction or end-systolic volume. 
Correlation between Tc-99m sestamibi infarct size and 
computed tomographic measurements. Technetium-99m ses- 
tamibi nfarct size did not correlate with end-systolic volume at 
discharge but demonstrated a highly significant correlation at 6 
weeks, 6 months (not shown) and 1 year (Fig. 2). Infarct size 
did not correlate with end-diastolic volume at discharge, but 
the correlation between these measures improved with time 
and reached borderline significance at 6 months (r = 0.55, p : 
0.05) and i year (r = 0.44, p = 0.11). Correlation of infarct size 
with ejection fraction followed a pattern similar to that with 
end-systolic volume (Fig. 3). At discharge, there was no 
correlation, but by 6 weeks the relation was highly significant 
and persisted to 1 year. 
Patients with the largest infarct size demonstrated the 
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Figure 1. Distribution of end-systolic volume 
(ESV) through four points in time after acute 
infarction• Box plots represent median value 
and 25th and 75th percentiles with the 10th and 
90th percentiles; outliers are plotted separately 
(circles). There was a significant increase in 
end-systolic volume over 1 year (p < 0.0001). 
greatest amount of dilation and decline in ejection fraction 
(Fig. 4). Both changes in end-systolic volume and ejection 
fraction were linearly related to infarct size by Tc-99m sesta- 
mibi assessed at discharge (r = 0.63, p = 0.02 for infarct size 
vs. 1-year end-systolic volume change; r = -0.66, p = 0.01 for 
infarct size vs. 1-year ejection fraction change). By multivariate 
analysis, infarct size was the most powerful predictor of 
subsequent change in end-systolic volume and ejection fraction 
(p < 0.001 for both measures). However, change in diastolic 
blood pressure was independently related to the change in 
these variables after adjustment for infarct size. Increase in 
diastolic blood pressure was independently associated with an 
increase in end-systolic volume (p = 0.005) and was inversely 
associated with a change in ejection fraction (p = 0.05). No 
other hemodynamic variables provided significant information. 
Discuss ion  
The results of the present study suggest that the size of the 
initial infarction is a primary determinant of subsequent 
changes in left ventricular geometry and performance in 
patients in whom the status of the infarct-related artery is 
uniform. There was initially no correlation between infarct size 
and ejection fraction or end-systolic volume despite the use of 
highly accurate measures of all three variables. Not until 
remodeling had progressed was there a significant relation 
among these variables. There was an overall significant in- 
crease in end-systolic volume over 1 year, with preservation f
left ventricular ejection fraction. Patients with the largest 
infarcts assessed by Tc-99m sestamibi at discharge developed 
the largest increases in end-systolic volume over the ensuing 
year despite presumed patency of the infarct-related artery 
during this time. Only patients with an infarct size involving 
>25% of the left ventricle demonstrated a decrease in left 
ventricular ejection fraction >5% in the subsequent year. 
Animal studies (4,22-24) have clearly shown that left 
ventricular emodeling and subsequent changes in systolic 
function are linearly related to infarct size. In the rat model, 
progressive increases in ventricular volumes occurred largely 
on the basis of initial infarct size despite maintenance of 
constant filling pressures (4). Furthermore, the process of 
ventricular dilation progressed far beyond the time point when 
infarct healing was complete, suggesting that a global adaptive 
process to a reduction in contractile function within the infarct 
zone may be responsible for these late changes (23,24). Dila- 
tion can enhance contractility in the noninfarct walls to 
maintain stroke volume but at a cost of increasing wall tension 
(25). The increases in wall tension can lead to further ventric- 
ular dilation, and this process will be most marked when the 
decline in contractile function from necrosis is large (26). 
These observations have been confirmed in clinical studies of 
myocardial infarction (27-30). 
Table 2. Hemodynamic  and Computed Tomographic  Measurements  (mean _+ SD) Over 1 Year* 
p Value 
Discharge 6 wk 6 mo 1 yr (ANOVA) 
Heart rate (beats/rain) 70 _+ 10 63 + 12 64 + 12 63 + 12 0.05 
Systolic BP (ram Hg) 110 + 7 104 _+ 14 I i I  _+ 13 120 _+ 19 0.03 
Diastolic BP (mm Hg) 67 _+ 8 69 _+ 8 71 _+ 10 78 +_ 13 0.001 
ESV (ml) 54 + 17 67 _+ 16 69 _+ 19 76 _+ 25 < 0.0001 
EDV (ml) 136 _+ 17 146 +_ 21 158 _+ 17 171 _+ 21 < 0.0001 
EF 0.60 _+ 0.09 0.57 + 0.10 0.57 + 0.10 0.56 -+ 0.12 0.13 
*One patient who did not have a scan at 6 months was omitted from the analysis. ANOVA = analysis of variance; 
BP - blood pressure; EDV (ESV) - end-diastolic (end-systolic) volume; EF = ejection fraction. 
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Figure 2. Correlation between tom•graphic technetium-99m sesta- 
mibi infarct size at hospital discharge and left ventricular (LV) 
end-systolic volume (ESV) by electron beam computed tomography at 
(A) discharge, (B) 6 weeks and (C) 1 year. 
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Figure 3. Correlation between tom•graphic technetium-99m sesta- 
mibi nfarct size at hospital discharge and left ventricular (LV) ejection 
fraction (EF) at (A) discharge, (B) 6 weeks and (C) 1 year. 
Counterbalancing the effect of infarct size on subsequent 
left ventricular remodeling is the presence of preserved blood 
flow to the infarct zone. Hochman and Choo (3), as well as 
others (31,32), have demonstrated an independent effect of 
preserved blood flow to the infarct zone on subsequent left 
ventricular dilation. The attenuation of this adaptive mecha- 
nism in clinical studies appears to be brought on either by 
restored anterograde flow down the infarct-related artery 
(32,33) or by preserved collateral flow from donor vessels (31). 
The mechanism of this effect is most likely accelerated healing 
within the infarct zone, preventing nonischemic nfarct expan- 
sion (34). To avoid the confounding impact of infarct-related 
artery patency on subsequent changes in left ventricular di- 
mensions, only patients with patent arteries were included in 
the present study. The linear correlation between infarct size 
and subsequent changes in end-systolic volume, as shown by 
the current study, suggests that preserved blood flow to the 
infarct zone independent of myocardial salvage cannot prevent 
remodeling when the extent of necrosis is large. 
Previous studies. The present results are in agreement 
with several previous studies that used serial radionuclide 
angiography to follow ventricular volume after myocardial 
infarction. Jeremy et al. (28) showed marked increases in 
ventricular volumes in patients not receiving reperfusion ther- 
apy. These changes were most pronounced inthe patients with 
the lowest ejection fraction or largest extent of wall motion 
abnormalities at the start of the study. Warren et al. (35) found 
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Figure 4. Change in left ventricular (LV) end-systolic volume (ESV) 
(top) and left ventricular ejection fraction (EF) (bottom) over 1 year 
(1-year value minus discharge value) as a function of tomographic 
technetium-99m sestamibi infarct size. There is a significant linear 
correlation for the change in both computed tomographic measure- 
ments. Horizontal line at zero represents a value of no change over 1 
year for end-systolic volume or ejection fraction. 
that patients with an anterior infarction demonstrated signifi- 
cantly greater changes in left ventricular volumes than patients 
with an inferior infarct despite successful but late reperfusion 
therapy. A study from our laboratory (17) has shown that both 
myocardium atrisk and final infarct size are more than twice as 
great in patients with an anterior compared with those with an 
inferior myocardial infarction. 
This study differs from a previous report from this labora- 
tory (7), where left ventricular volumes and function by gated 
equilibrium radionuclide ventriculography during the year 
after infarction were compared with Tc-99m sestamibi infarct 
size at hospital discharge in patients with a patent infarct- 
related artery. In that study there was no significant change in 
ventricular volumes over 1 year despite the extent of infarct 
size. The most probable xplanation of this discrepancy is the 
use of a more accurate method of measuring left ventricular 
volumes by electron beam computed tomography. In the 
previous tudy, a significant change in end-systolic volume was 
defined as 26 ml for radionuclide ventriculography, whereas in 
the present study, the mean change for the group was 24 ml by 
electron beam computed tomography. The superior resolution 
and lack of a need to correct for chest wall attenuation allows 
more precise ventricular measurements using electron beam 
computed tomography. 
Hemodynamie ffects. Although infarct size appeared to be 
the primary determinant of subsequent changes in left ventric- 
ular volume and function, changes in diastolic blood pressure 
at the time of the four scans had an impact on the results. 
Systemic diastolic pressure progressively increased for the 
group during each of the scans. This finding was also reported 
in two clinical studies by Pfeffer et al. (36,37), who observed a
significant increase in mean arterial pressure over 1 year in 
both patient groups randomized to receive angiotensin- 
converting enzyme inhibitors or placebo after myocardial 
infarction. Clearly, loading conditions can affect left ventricu- 
ar performance and, consequently, volume changes (38). This 
:ffect was weaker than infarct size in the current study, but it 
underscores the importance of factoring in hemodynamic 
variables when analyzing serial changes in ventricular function 
in clinical studies. 
Study limitations. The study group was small; however, the 
relations between infarct size and left ventricular volumes and 
ejection fraction were highly significant. Although the study 
was designed to evaluate patients at 6 weeks, the actual timing 
of the second electron beam computed tomographic s an was 
closer to 9 weeks. Of potential concern is the unavailability of 
late coronary angiograms for the study group. Silent reocclu- 
sion of the infarct-related artery shortly after reperfusion 
cannot be excluded as a potential explanation of these results. 
However, no patient had documented myocardial necrosis in 
the year after myocardial infarction. Because ventricular vol- 
umes may change early in the course of acute myocardial 
infarction, a potential source of error is the inability to assess 
ventricular volumes earlier than hospital discharge, although 
presumably the correlation with infarct size would have been 
even weaker at that time. Only one patient received angioten- 
sin-converting enzyme inhibitor therapy after infarction. Given 
the well documented effects of these agents (37,39,40), the 
results cannot be extrapolated to a patient group placed on 
angiotensin converting enzyme inhibitors therapy; nor can 
these results be universally applied to patients with inferior 
infarction because only two were included in the study group. 
Conclusions. The findings of this study suggest hat pa- 
tients most likely to develop progressive l ft ventricular dila- 
tion after an index myocardial infarction can be identified 
prospectively at hospital discharge using Tc-99m sestamibi 
tomographic imaging. Such patients probably benefit he most 
from initiation of angiotensin-converting enzyme inhibitor 
therapy, but this hypothesis requires confirmation i  a prospec- 
tive clinical trial. 
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